NCT00848042View on ClinicalTrials.gov

Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Head and Neck Cancer
Interventions
DEVICE

AuroLase Therapy

Infusion of AuroShell particles followed by laser illumination for photothermal ablation of target lesions

Trial Locations (2)

77030

Baylor College of Medicine, Houston

85338

Cancer Treatment Centers of American Western Regional Medical Center, Goodyear

Sponsors
All Listed Sponsors
lead

Nanospectra Biosciences, Inc.

INDUSTRY

NCT00848042 - Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck | Biotech Hunter | Biotech Hunter